✦ LIBER ✦

Significant Reductions in Drinking Following Brief Alcohol Treatment Provided in a Hepatitis C Clinic

✍ Scribed by Eric Dieperink; Samuel B. Ho; Sara Heit; Janet M. Durfee; Paul Thuras; Mark L. Willenbring

Book ID: 117199681
Publisher: American Psychiatric Publishing Inc
Year: 2010
Tongue: English
Weight: 110 KB
Volume: 51
Category: Article
ISSN: 1545-7206
DOI: 10.1016/s0033-3182(10)70675-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Commentary on Gibson et al. (2011): Brie

Commentary on Gibson et al. (2011): Brief alcohol interventions in the context of treatment for hepatitis C

✍ MICHAEL A. CUCCIARE; KENNETH R. WEINGARDT 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Liver stiffness measurement as a predict

Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis

✍ M. LEMOINE; S. KATSAHIAN; M. ZIOL; P. NAHON; N. GANNE-CARRIE; F. KAZEMI; V. GRAN 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB

Long term response to interferon treatme

Long term response to interferon treatment in chronic hepatitis C patients is associated with a significant reduction in anti-E1 envelope antibody titers

✍ Depraetere, Stany; Van Kerschaever, Els; Van Vlierberghe, Hans; Elewaut, Andr�; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

Interferon (IFN) alfa has been used widely for the treatment of chronic hepatitis C virus (HCV) infections but only a small number of patients treated have shown a sustained biochemical and virological response. Anti-envelope E1 and E2 antibody titers were assessed retrospectively before, during, an

584 Long-term low dose treatment with pe

584 Long-term low dose treatment with pegylated interferon α-2b leads to a significant reduction in fibrosis in chronic hepatitis C nonresponder patients

✍ S. Kaiser; H. Hass; B. Lutze; M. Gregor 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 123 KB